Your Blood Pressure Is High at the Doctor’s — But Normal at Home. Here’s What That Means.

What is white coat hypertension?

White coat hypertension (WCH) is defined as elevated blood pressure in a clinical setting — typically a doctor’s office or hospital — while readings taken outside that environment remain normal. The name comes from the white coats traditionally worn by medical professionals, which some patients associate with anxiety or stress.

Is it actually harmless?

For a long time, white coat hypertension was dismissed as a benign quirk. Newer research paints a more nuanced picture. A meta-analysis of 27 studies found that untreated white coat hypertension was associated with meaningfully higher risk compared to people with consistently normal blood pressure:

• +36% increased risk of cardiovascular events
• +33% increased risk of all-cause mortality
• +109% increased risk of cardiovascular mortality

That said, the risk is still lower than sustained hypertension, where blood pressure is high both in and out of the clinic. Think of white coat hypertension as an intermediate state: not harmless, but not equivalent to full hypertension either.

There is another concern: people with white coat hypertension tend to progress to sustained hypertension more quickly than those with consistently normal readings. This makes ongoing monitoring essential, rather than a one-time reassurance.

How is it diagnosed?

Diagnosis requires blood pressure measurement outside the clinical environment. Two main methods are used:

• Ambulatory blood pressure monitoring (ABPM) — a device worn for 24 hours that records readings throughout the day and night. This is the preferred method for initial diagnosis.
• Home blood pressure monitoring (HBPM) — taking readings at home using a validated device, typically over several days.

According to the 2025 AHA/ACC Hypertension Guidelines, out-of-office monitoring is recommended for any adult with an office blood pressure reading at or above 130/80 mmHg, to rule out white coat hypertension before starting treatment.

What should you do if you have it?

Treatment decisions for white coat hypertension depend largely on your overall cardiovascular risk profile. Currently, there is no high-quality randomized trial evidence proving that antihypertensive medication reduces cardiovascular risk specifically in white coat hypertension, so medication is not automatically prescribed.

Here is the general approach recommended by current guidelines:

• Annual monitoring with ABPM or HBPM to detect any transition to sustained hypertension
• Lifestyle modifications including weight management, regular physical activity, moderate salt reduction, and smoking cessation
• Management of other cardiovascular risk factors such as cholesterol and blood sugar
• Medication may be considered in those with high cardiovascular risk, or when office readings are 160/100 mmHg or above where white coat hypertension is less likely to be the sole explanation

Conclusion

White coat hypertension is real, it is common, and it is not something to simply ignore. While it carries lower risk than sustained hypertension, it is not a clean bill of health either. However, with the right monitoring strategy and lifestyle habits, it is entirely manageable.

If your blood pressure reading spikes at the clinic but feels normal at home, talk to your doctor about out-of-office monitoring. Getting an accurate picture of your blood pressure is the first step and arguably the most important one.

Related: High Blood Pressure Screening, DASH Diet – Eat Your Way to Lower Blood Pressure, How To Lower Blood Pressure Without Medications?

References:

• Cohen JB et al. Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-Analysis. Ann Intern Med. 2019.
• Tientcheu D et al. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension. J Am Coll Cardiol. 2015.
• Jones DW et al. 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2025.
• Mancia G et al. White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage. Hypertension. 2022.
• Muntner P et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019.
• Weinfeld JM et al. Home Blood Pressure Monitoring. Am Fam Physician. 2021.
• Filippone EJ et al. Controversies in Hypertension I: The Optimal Assessment of Blood Pressure Load and Implications for Treatment. Am J Med. 2022.
• Chrysant SG. Treatment of White Coat Hypertension. Curr Hypertens Rep. 2000.